Brooktree Capital Management cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 49.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,661 shares of the healthcare product maker’s stock after selling 2,585 shares during the […]
Argus upgraded shares of Rocket Companies (NYSE:RKT – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Monday, The Fly reports. RKT has been the topic of a number of other research reports. Citigroup upped their target price on shares of Rocket Companies from $8.00 to […]
Rocket Companies (NYSE:RKT – Get Rating) had its price target boosted by Citigroup from $8.00 to $9.00 in a report issued on Friday, The Fly reports. RKT has been the subject of a number of other research reports. Credit Suisse Group reaffirmed an underperform rating and set a $7.00 price target on shares of Rocket […]
Brooktree Capital Management trimmed its position in shares of HEICO Co. (NYSE:HEI – Get Rating) by 76.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,694 shares of the aerospace company’s stock after selling 5,528 shares during the quarter. Brooktree Capital Management’s holdings […]
Brooktree Capital Management trimmed its stake in shares of BlackRock, Inc. (NYSE:BLK – Get Rating) by 31.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 678 shares of the asset manager’s stock after selling 311 shares during the period. BlackRock makes up about 0.4% of Brooktree Capital Management’s holdings, making the stock its […]